“Omics” and Immunologic Approaches to Optimizing Cure Rates in HER2-Positive Breast Carcinomas

by Tagliabue, Elda, Campiglio, Manuela
Published in Front Oncol (2014)

Reprogramming the lung microenvironment by inhaled immunotherapy fosters immune destruction of tumor

by Le Noci, Valentino, Sommariva, Michele, Tortoreto, Monica, Zaffaroni, Nadia, Campiglio, Manuela, Tagliabue, Elda, Balsari, Andrea, Sfondrini, Lucia
Published in Oncoimmunology (2016)

FHIT-proteasome degradation caused by mitogenic stimulation of the EGF receptor family in cancer cells

by Bianchi, Francesca, Magnifico, Alessandra, Olgiati, Clelia, Zanesi, Nicola, Pekarsky, Yuri, Tagliabue, Elda, Croce, Carlo Maria, Ménard, Sylvie, Campiglio, Manuela
Published 2006

Wound Healing Fluid Reflects the Inflammatory Nature and Aggressiveness of Breast Tumors

by Agresti, Roberto, Triulzi, Tiziana, Sasso, Marianna, Ghirelli, Cristina, Aiello, Piera, Rybinska, Ilona, Campiglio, Manuela, Sfondrini, Lucia, Tagliabue, Elda, Bianchi, Francesca
Published in Cells (2019)

Extracellular Matrix Features Discriminate Aggressive HER2-Positive Breast Cancer Patients Who Benefit from Trastuzumab Treatment

by Rybinska, Ilona, Sandri, Marco, Bianchi, Francesca, Orlandi, Rosaria, De Cecco, Loris, Gasparini, Patrizia, Campiglio, Manuela, Paolini, Biagio, Sfondrini, Lucia, Tagliabue, Elda, Triulzi, Tiziana
Published in Cells (2020)

The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control

by Sard, Laura, Accornero, Paola, Tornielli, Silvana, Delia, Domenico, Bunone, Giuseppe, Campiglio, Manuela, Colombo, Mario P., Gramegna, Marcella, Croce, Carlo M., Pierotti, Marco A., Sozzi, Gabriella
Published 1999

Circulating Biomarkers in Advanced Colorectal Cancer Patients Randomly Assigned to Three Bevacizumab-Based Regimens

by Martinetti, Antonia, Miceli, Rosalba, Sottotetti, Elisa, Di Bartolomeo, Maria, de Braud, Filippo, Gevorgyan, Arpine, Dotti, Katia Fiorella, Bajetta, Emilio, Campiglio, Manuela, Bianchi, Francesca, Bregni, Giacomo, Pietrantonio, Filippo
Published 2014

Tyrosine Phosphorylation of Grb2: Role in Prolactin/Epidermal Growth Factor Cross Talk in Mammary Epithelial Cell Growth and Differentiation

by Haines, Eric, Minoo, Parham, Feng, Zhenqian, Resalatpanah, Nazila, Nie, Xin-Min, Campiglio, Manuela, Alvarez, Laura, Cocolakis, Eftihia, Ridha, Mohammed, Di Fulvio, Mauricio, Gomez-Cambronero, Julian, Lebrun, Jean-Jacques, Ali, Suhad
Published 2009

Nitrilase and Fhit homologs are encoded as fusion proteins in Drosophila melanogaster and Caenorhabditis elegans

by Pekarsky, Yuri, Campiglio, Manuela, Siprashvili, Zurab, Druck, Teresa, Sedkov, Yurii, Tillib, Sergei, Draganescu, Alexandra, Wermuth, Peter, Rothman, Joel H., Huebner, Kay, Buchberg, Arthur M., Mazo, Alexander, Brenner, Charles, Croce, Carlo M.
Published 1998

The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer

by Forte, Luca, Turdo, Federica, Ghirelli, Cristina, Aiello, Piera, Casalini, Patrizia, Iorio, Marilena Valeria, D’Ippolito, Elvira, Gasparini, Patrizia, Agresti, Roberto, Belmonte, Beatrice, Sozzi, Gabriella, Sfondrini, Lucia, Tagliabue, Elda, Campiglio, Manuela, Bianchi, Francesca
Published in BMC Cancer (2018)

Whole-transcriptome analysis links trastuzumab sensitivity of breast tumors to both HER2 dependence and immune cell infiltration

by Triulzi, Tiziana, De Cecco, Loris, Sandri, Marco, Prat, Aleix, Giussani, Marta, Paolini, Biagio, Carcangiu, Marialuisa L., Canevari, Silvana, Bottini, Alberto, Balsari, Andrea, Menard, Sylvie, Generali, Daniele, Campiglio, Manuela, Di Cosimo, Serena, Tagliabue, Elda
Published in Oncotarget (2015)

CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers

by Turdo, Federica, Bianchi, Francesca, Gasparini, Patrizia, Sandri, Marco, Sasso, Marianna, De Cecco, Loris, Forte, Luca, Casalini, Patrizia, Aiello, Piera, Sfondrini, Lucia, Agresti, Roberto, Carcangiu, Maria Luisa, Plantamura, Ilaria, Sozzi, Gabriella, Tagliabue, Elda, Campiglio, Manuela
Published in Oncotarget (2016)

PDGFRβ and FGFR2 mediate endothelial cell differentiation capability of triple negative breast carcinoma cells

by Plantamura, Ilaria, Casalini, Patrizia, Dugnani, Erica, Sasso, Marianna, D'Ippolito, Elvira, Tortoreto, Monica, Cacciatore, Matilde, Guarnotta, Carla, Ghirelli, Cristina, Barajon, Isabella, Bianchi, Francesca, Triulzi, Tiziana, Agresti, Roberto, Balsari, Andrea, Campiglio, Manuela, Tripodo, Claudio, Iorio, Marilena V., Tagliabue, Elda
Published in Mol Oncol (2014)